Mydriasert 0.28mg/5.4mg Ophthalmic Insert: Company-led recall
Yes – this has been recalled
- The problem
- Thea Pharmaceuticals are recalling a specific batch of Mydriasert 0.28mg/5.4mg Ophthalmic Insert as it is labelled as being for the French market, rather than the UK market.
- What to do
- Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Source: Medicines and Healthcare products Regulatory Agency (MHRA)
Official notice ↗
Product information
CLDA number
CLDA (18)A/07
MDR number
MDR 15-09/18
Company name
Thea Pharmaceuticals
Product description
Mydriasert 0.28mg/5.4mg Ophthalmic Insert PL 20162/0011
Batch number/expiry
| Batch Number | Expiry Date |
| B208811B49C | July 2019 |
Brief description of the problem
The above batch, which has inadvertently been distributed in the UK, is being recalled because it is labelled for the French market.
Company contact for general enquiries:
Christine Purslow
Tel: 07889 535 661
Email chris.purslow@theapharm.com
Company contact for further information enquiries:
Medical Information line: 0345 521 1290
Updated 11 September 2018. This page summarises an official notice. Details can change – always follow the official notice.